This track focuses on the impact of nutrient deficiencies and obesity on pediatric populations. It aims to explore innovative nutritional strategies and their role in preventing chronic diseases in children.

This session will delve into child psychology and behavioral studies related to pediatric cardiac patients. It will address the psychological challenges faced by children with heart conditions and their families.

This track will examine contemporary pain relief therapies and management strategies for pediatric patients. Emphasis will be placed on evidence-based practices and innovative approaches to enhance patient comfort.

This session will highlight the latest advancements in neonatal diagnosis and surgical techniques. It aims to improve outcomes for newborns with congenital heart defects and other critical conditions.

This track will explore regenerative cardiac surgery techniques and their applications in pediatric patients. Discussions will focus on the potential for tissue engineering and stem cell therapies in improving surgical outcomes.

This session will address the complexities and complications associated with pediatric cardiovascular surgery. It will provide insights into best practices for managing surgical risks and enhancing recovery.

This track will focus on the role of interventional cardiology in the management of congenital and acquired heart diseases in pediatric patients. It will cover the latest techniques and their clinical implications.

This session will investigate the causes and management of myocardial dysfunction in children. It aims to enhance understanding of this condition and improve diagnostic and therapeutic strategies.

This track will explore congenital and acquired immune deficiencies in children. It will discuss the latest research on vaccination, complications, and management strategies for pediatric patients.

This session will address the prevalence and management of community-acquired infections among children. It will focus on preventive measures and the role of healthcare providers in mitigating risks.

This track will examine the latest advancements in drug development and diagnostics tailored for pediatric populations. It will highlight the importance of age-appropriate formulations and safety considerations.